24 September 2019 in IEEE Transactions on Electron Devices
The N-polar GaN high-electron mobility transistors (HEMTs) have demonstrated a powerful performance as the Ga-polar GaN HEMTs. This investigation aims to show the direct current performance and cutoff frequency (fT) of the planar N-polar GaN HEMTs with gate lengths downscaling from 4 μm to 50 nm by 2-D device simulation. The impacts of traps and gate dielectrics and the roles of the field-dependent mobility and the source and drain series resistances are investigated. For our central-gated device with a 10-nm top GaN channel layer, a 30-nm Al0.3Ga0.7N barrier layer, and a 3-nm Al₂O₃ gate dielectric, the gate length (LG) as the transition point from the long-channel behavior to the short-channel one is found to be 200 nm. For LG < 200 nm, a linear fT⁻¹ versus LG relation shows up, and notable short-channel effects appear, i.e., the negative shift of the threshold voltage, the increase of the drain-induced barrier lowering, and the almost LG-independent constant maximum transconductance in the saturation region. The degradation of the fTx LG product with the decrease in the aspect ratio between LG and the equivalent gate-channel distance (tt) is shown to be quite small. The LG/tt ratio for 15% degradation of the fTx LG product from its upper limit (19.23 GHz·μ m) is 5.5. This small degradation of the frequency characteristics in short-channel devices is attributed to the quite small fringing capacitance of the gate.
1 January 2021 in Indian Journal of Pharmaceutical Sciences
To investigate the diagnostic value of chitinase-3-like protein 1 and keratin 5 in bronchoalveolar lavage fluid in 88 patients with lung disease. This was a case control study to collect 50 patients with lung cancer (malignant disease group) and 38 patients with benign lung disease (benign disease group) who were admitted to the respiratory medicine department in the affiliated hospital of medical school of Ningbo university from December 2019 to March 2020. The enzyme-linked immunosorbent assay was applied to detect the expression levels of chitinase-3-like protein 1 and keratin 5 in bronchoalveolar lavage fluid of the two groups of the patients. The diagnostic effect was evaluated using the subject's working characteristics to establish a diagnostic mathematical model. The levels of chitinase-3-like protein 1 and keratin 5 in bronchoalveolar lavage fluid were significantly higher in the malignant disease group than in the benign disease group (p<0.05). These two (chitinase-3-like protein 1 and keratin 5) were significantly correlated and positively correlated and the combined test could significantly improve the sensitivity and specificity of lung cancer diagnosis. The diagnostic rate of chitinase-3-like protein 1 and keratin 5 for lung cancer. The chitinase-3-like protein 1 in bronchoalveolar lavage fluid and carcinoembryonic antigen in blood combined was superior to chitinase-3- like protein 1 or keratin 5 alone in the diagnosis of lung cancer. Chitinase-3-like protein 1 and keratin 5 in bronchoalveolar lavage fluid contribute to the early diagnosis of lung cancer and can be used as biomarkers for the diagnosis of lung cancer with high sensitivity and specificity. The application of the two combined assays as molecular markers for clinical diagnosis and as targeted therapeutic agents needs to be further studied.